Endocrinol Metab.  2024 Oct;39(5):699-700. 10.3803/EnM.2024.2189.

Combining Nationwide Cohorts to Unveil the Predictive Role of Insulin Resistance and Impaired Insulin Secretion in Diabetes

• Kim B

• KMID: 2560278
• DOI: http://doi.org/10.3803/EnM.2024.2189

Reference

1. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009; 104:861–7.

2. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014; 383:1068–83.

3. Jo H, Ahn S, Ohn JH, Shin CM, Ji E, Kim D, et al. Insulin resistance and impaired insulin secretion predict incident diabetes: a statistical matching application to the two Korean nationwide, population-representative cohorts. Endocrinol Metab (Seoul). 2024; 39:711–21.

4. Wang T, Lu J, Shi L, Chen G, Xu M, Xu Y, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020; 8:115–24.

5. Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Miyamatsu N, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia. 2013; 56:1671–9.

6. Yabe D, Seino Y. Type 2 diabetes via β-cell dysfunction in east Asian people. Lancet Diabetes Endocrinol. 2016; 4:2–3.